Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Current Assets: 2020-2025

Historic Current Assets for Journey Medical (DERM) over the last 4 years, with Sep 2025 value amounting to $56.4 million.

  • Journey Medical's Current Assets rose 22.15% to $56.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.4 million, marking a year-over-year increase of 22.15%. This contributed to the annual value of $48.2 million for FY2024, which is 14.66% down from last year.
  • Per Journey Medical's latest filing, its Current Assets stood at $56.4 million for Q3 2025, which was up 9.98% from $51.3 million recorded in Q2 2025.
  • Journey Medical's 5-year Current Assets high stood at $90.3 million for Q1 2022, and its period low was $44.7 million during Q3 2023.
  • Moreover, its 3-year median value for Current Assets was $48.2 million (2024), whereas its average is $50.8 million.
  • Its Current Assets has fluctuated over the past 5 years, first soared by 139.75% in 2021, then crashed by 43.86% in 2023.
  • Journey Medical's Current Assets (Quarterly) stood at $84.5 million in 2021, then dropped by 8.06% to $77.7 million in 2022, then declined by 27.32% to $56.5 million in 2023, then fell by 14.66% to $48.2 million in 2024, then climbed by 22.15% to $56.4 million in 2025.
  • Its Current Assets was $56.4 million in Q3 2025, compared to $51.3 million in Q2 2025 and $54.0 million in Q1 2025.